aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1
Authors:
Open Access
- 1 April 2019
- journal article
- research article
- Published by Elsevier in Redox Biology
- Vol. 22, 101149
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81172015, 81572417)
- Huazhong University of Science and Technology (540- 5001540068)
This publication has 49 references indexed in Scilit:
- CDK20 interacts with KEAP1 to activate NRF2 and promotes radiochemoresistance in lung cancer cellsOncogene, 2017
- Genomic spectra of biliary tract cancerNature Genetics, 2015
- Proteomic Analysis of Ubiquitin Ligase KEAP1 Reveals Associated Proteins That Inhibit NRF2 UbiquitinationCancer Research, 2013
- Role of Nrf2 in Oxidative Stress and ToxicityAnnual Review of Pharmacology and Toxicology, 2013
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signalingCellular Signalling, 2012
- Gallbladder cancer: Can newer insights improve the outcome?Journal of Gastroenterology and Hepatology, 2012
- SCF/β-TrCP Promotes Glycogen Synthase Kinase 3-Dependent Degradation of the Nrf2 Transcription Factor in a Keap1-Independent MannerMolecular and Cellular Biology, 2011
- Protein kinase Cι expression and oncogenic signaling mechanisms in cancerJournal of Cellular Physiology, 2010
- The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 LigaseMolecular and Cellular Biology, 2004
- Induction of Apoptosis by Protein Kinase Cδ Is Independent of Its Kinase ActivityJournal of Biological Chemistry, 2002